Magic Mushrooms & Vascular Headaches
Certain species of mushrooms have long been used to treat vascular headaches. This dates back to witch doctors and medicine men. The author Lewis Carrol was known to suffer from migraine and is also suspected of using magic mushrooms.
In recent times, some people occasionally using either LSD or magic mushrooms recreationally have noticed a correlation between the use of these substances and a remarkable improvement in their condition. In fact a mysterious absence of headaches. However, there is also anecdotal evidence from frequent abusers of both substances citing the exact opposite, that these substances have worsened their condition.
What is clear is that these substances certainly have an effect on vascular headaches. It would also appear that occasional consumption of relatively low doses may bring about a remission, whereas regular consumption at higher doses may exacerbate the condition. This is not an altogether unusual occurrence among conventional treatments. For instance, radiation can both cure and cause cancer.
There are dozens of species of magic mushroom. They can occasionally be obtained via drug dealers (see also procuring lsd). The most common method of procurement is to go out and pick some. This is inherently dangerous since only a trained eye can tell certain species apart. The biggest risk is from accidentally ingesting a poisonous species. It is best to take a trained eye along, and then perform identification as advised by a textbook.
The safest route is to grow a personal supply. The mushroom spores are completely legal (almost everywhere) and can therefore be sourced via mail order, as can the necessary equipment. Some species are easy to grow, and can be cultivated within 6 weeks. See our FAQ
Fresh psilocybe mushrooms are legally sold in Amsterdam and in some
parts of the UK. Their use as a headache treatment is becoming more widely
known to the shop owners and may be of some help discussing their products
for this purpose.
Many people have begun growing their own supply. This is a very inexpensive way of supplying themselves with enough psilocybin to complete their treatments. This is also the safest way of knowing exactly what you have. Growing details and additional links can be found in section 3 of our FAQ
The biggest danger with psilocybin mushrooms is that psilocybin mushrooms are almost identical to poisonous varieties. Organ damage and death can occur within hours of eating poisonous mushrooms.
There are no documented cases of anyone dying from the toxic effects of either LSD or (the correct) mushrooms. It is virtually impossible to obtain and ingest enough of these essentially non-toxic substances.
The often related old story about someone jumping out of a window was not a result of ingesting LSD or mushrooms, but rather a completely unrelated drug known as PCP or 'Angel Dust'.
You aren't going to go on a trip and "never back".
Only people with previously existing serious mental problems are at risk of exacerbating those problems through the use of these substances."
These substances are classified as counter-addictive. It is widely believed to be impossible to become dependant on them.
You'll need acrobat reader for this interesting report.
This is a report by the Coordination Centre for the Assessment and Monitoring of New Drug (CAM), a Dutch government body, into the risk assessment of paddos (psilocin & psilocybin), i.e., magic mushrooms.
The report was commissioned by the Dutch government when they were looking at banning the sale of magic mushrooms in The Netherlands and led to fresh magic mushrooms being a legal and taxed product in Holland.
The report concludes that magic mushrooms are of low risk to individual health and society in general. Although, it recommended the need for quality requirements to be imposed, (such as standardisation, purity and labelling), it said the results of the risk assessment did not present any need for a statutory ban on magic mushrooms. The report was translated by an accredited sworn translator for the English language, who has signed a legal document to say the translation of the CAM study is a full, true and faithful translation.
Genetic toxicology of lysergic acid diethylamide (LSD-25).
Cohen MM, Shiloh Y.
The acute and the chronic psychotomimetic potentials of the hallucinogen lysergic acid diethylamide (LSD-25) have been recognized for almost 40 years. That additional types of the biological effects should have come under scrutiny was directly attributable to widespread use and abuse of this drug on a world-wide basis. Although "genetic toxicology" encompasses a broad spectrum of disciplines, including many areas of highly specialized research, perhaps the most germane, and those on which this review has concentrated, are Clastogenicity, Mutagenicity, Teratogenicity and Oncogenicity. Based on our current understanding and interpretation of the available data, the genetic toxicology of LSD provides an excellent example of Newton's "third law of motion", e.g., to every force there is an equal and opposite reaction force. From the published material it is impossible to draw clear cut conclusions regarding any of the above "problem areas" in spite of the considerable scientific effort invested. Most of the in vitro studies performed on the clastogenicity of LSD indicate either suppression of mitosis or enhanced chromosome damage. However, extrapolation of such results to the in vivo situation is very difficult. With regard to in vivo human use of the drug, no concensus is attainable as to chromosome breakage and the inconsistencies within and between studies remain inexplicable. However, several of the "controlled" investigations assessing the in vivo effect of chemically pure LSD suggest a transient increase in lymphocyte chromosome breakage. On the other hand, the results of cytogenetic studies on experimental animals are contradictory. Although human studies are nonexistent, in those experimental organisms tested, using accepted techniques, LSD proved to be, at best, a weak mutagen, if mutagenic at all. Teratogenicity studies in animals are confusing due to the multitude of organisms and plethora of discriminant parameters studied. However, with regard to man there has been ample opportunity and one can conclude that LSD is not teratogenic. As to the drug's oncogenic potential, the 3 reported cases of leukemia in LSD users are most likely the result of coincidence.